sORF constructs and multiple gene expression

Details for Australian Patent Application No. 2010313395 (hide)

Owner Abbott Laboratories

Inventors Carson, Gerald R.; Gion, Wendy R.; Kunes, Yune Z.; Leise III, Walter F.; Davis-Taber, Rachel A.; Fung, Emma

Agent Spruson & Ferguson

Pub. Number AU-A-2010313395

PCT Pub. Number WO2011/053699

Priority 61/256,544 30.10.09 US

Filing date 28 October 2010

Wipo publication date 5 May 2011

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Event Publications

10 May 2012 PCT application entered the National Phase

  PCT publication WO2011/053699 Priority application(s): WO2011/053699

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010313397-Phenoxy-substituted pyrimidines as opioid receptor modulators

2010313392-Pyrazines as delta opioid receptor modulators